• Journal Article

"Same-Day" administration of pegfilgrastim following myelosuppressive chemotherapy: clinical practice and provider rationale

Citation

Marion, S., Tzivelekis, S., Darden, C., Price, M., Sherif, B., Garcia, J., ... Chandler, D. (2016). "Same-Day" administration of pegfilgrastim following myelosuppressive chemotherapy: clinical practice and provider rationale. Supportive Care in Cancer, 24(9), 3889-3896. DOI: 10.1007/s00520-016-3193-3

Abstract

PURPOSE: To describe patient- and practice-related factors that physicians report affect their clinical decision to administer prophylactic pegfilgrastim to patients